ClariVest Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,322
Closed -$375K 842
2021
Q2
$375K Buy
2,322
+7
+0.3% +$1.13K 0.01% 456
2021
Q1
$396K Sell
2,315
-100
-4% -$17.1K 0.01% 446
2020
Q4
$530K Sell
2,415
-3,108
-56% -$682K 0.02% 367
2020
Q3
$917K Buy
+5,523
New +$917K 0.03% 310